» Articles » PMID: 34312259

NR4A3 Mediates Thymic Negative Selection

Overview
Journal J Immunol
Date 2021 Jul 27
PMID 34312259
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Central tolerance aims to limit the production of T lymphocytes bearing TCR with high affinity for self-peptide presented by MHC molecules. The accumulation of thymocytes with such receptors is limited by negative selection or by diversion into alternative differentiation, including T regulatory cell commitment. A role for the orphan nuclear receptor NR4A3 in negative selection has been suggested, but its function in this process has never been investigated. We find that transcription is upregulated in postselection double-positive thymocytes, particularly those that have received a strong selecting signal and are destined for negative selection. Indeed, we found an accumulation of cells bearing a negative selection phenotype in NR4A3-deficient mice as compared with wild-type controls, suggesting that transcriptional induction is necessary to limit accumulation of self-reactive thymocytes. This is consistent with a decrease of cleaved caspase-3-signaled thymocytes and more T regulatory and CD4Foxp3HELIOS cells in the NR4A3-deficient thymus. We further tested the role for NR4A3 in negative selection by reconstituting transgenic mice expressing the OVA Ag under the control of the insulin promoter with bone marrow cells from OT-I or OT-I mice. Accumulation of autoreactive CD8 thymocytes and autoimmune diabetes developed only in the absence of NR4A3. Overall, our results demonstrate an important role for NR4A3 in T cell development.

Citing Articles

Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.

Nielsen H, Yang L, Mueller J, Ritter A, Hiwa R, Proekt I Nat Commun. 2025; 16(1):784.

PMID: 39824797 PMC: 11742425. DOI: 10.1038/s41467-025-55839-5.


Potential Roles of Nr4a3-Mediated Inflammation in Immunological and Neurological Diseases.

He S, Jiang W, Jiang B, Yu C, Zhao G, Li Y Mol Neurobiol. 2024; 61(8):5958-5973.

PMID: 38261254 DOI: 10.1007/s12035-024-03945-8.


Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection.

Heimli M, Flam S, Sagsveen Hjorthaug H, Trinh D, Frisk M, Dumont K Front Immunol. 2023; 13:1092028.

PMID: 36741401 PMC: 9895842. DOI: 10.3389/fimmu.2022.1092028.